Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Cooper

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
Nature Medicine|July 18, 2018
Fetal gene therapy for neurodegenerative disease of infantsGiulia Massaro, Citra N Z Mattar, Andrew M S Wong, et al.
Science Translational Medicine|January 15, 2025
Gene therapy ameliorates bowel dysmotility and enteric neuron degeneration and extends survival in lysosomal storage disorder mouse modelsEwa A Ziółkowska, Matthew J Jansen, Letitia L Williams, et al.
The Journal of Clinical Investigation|August 30, 2022
Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheepHemanth R Nelvagal, Samantha L Eaton, Sophie H Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 18, 2022
Tralesinidase Alfa Enzyme Replacement Therapy Prevents Disease Manifestations in a Canine Model of Mucopolysaccharidosis Type IIIBN Matthew Ellinwood, Bethann N Valentine, Andrew S Hess, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
Nature Medicine|July 18, 2018
Fetal gene therapy for neurodegenerative disease of infantsGiulia Massaro, Citra N Z Mattar, Andrew M S Wong, et al.
Science Translational Medicine|January 15, 2025
Gene therapy ameliorates bowel dysmotility and enteric neuron degeneration and extends survival in lysosomal storage disorder mouse modelsEwa A Ziółkowska, Matthew J Jansen, Letitia L Williams, et al.
The Journal of Clinical Investigation|August 30, 2022
Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheepHemanth R Nelvagal, Samantha L Eaton, Sophie H Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 18, 2022
Tralesinidase Alfa Enzyme Replacement Therapy Prevents Disease Manifestations in a Canine Model of Mucopolysaccharidosis Type IIIBN Matthew Ellinwood, Bethann N Valentine, Andrew S Hess, et al.
Pageof 15